A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).

NCT00380796 · clinicaltrials.gov ↗

COMPLETED

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD
Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Collection of safety data for Cohort 1

Sponsor

Centocor, Inc.